Insight Molecular Q2 EPS $(0.30) Misses $(0.23) Estimate, Sales $518.000K Beat $292.000K Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsEarnings MissesNews
Insight Molecular (NASDAQ:IMDX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 16.67 percent increase over losses of $(0.36) per share
Insight Molecular (NASDAQ:IMDX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 16.67 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $518.000 thousand which beat the analyst consensus estimate of $292.000 thousand by 77.40 percent. This is a 398.08 percent increase over sales of $104.000 thousand the same period last year.